SO tamponade | Patients with IOP elevation | Patients without IOP elevation | ||||
---|---|---|---|---|---|---|
Affected eye | Healthy eye | P (Paired-t) | Affected eye | Healthy eye | P (Paired-t) | |
logMAR BCVA at follow up, Snellen equivalent | 0.48 ± 0.26 | 0.01 ± 0.06 | 0.001 | 0.50 ± 0.33 | 0.04 ± 0.05 | 0.005 |
FAZ, mm2 | 0.221 ± 0.090 | 0.347 ± 0.100 | 0.052 | 0.319 ± 0.111 | 0.331 ± 0.077 | 0.757 |
Parafoveal VD of SVC (%) | 38.69 ± 3.19 | 46.26 ± 2.32 | < 0.001 | 39.91 ± 4.01 | 44.55 ± 5.48 | 0.079 |
Parafoveal VD of DVC (%) | 50.10 ± 4.80 | 51.76 ± 4.95 | 0.482 | 52.34 ± 5.43 | 51.36 ± 3.31 | 0.716 |
Full retinal thickness, μm | 290.33 ± 26.95 | 316.22 ± 13.08 | 0.022 | 305.63 ± 29.53 | 305.13 ± 40.24 | 0.976 |
Inner retinal thickness, μm | 106.89 ± 13.66 | 128.89 ± 13.31 | 0.013 | 112.50 ± 19.02 | 127.88 ± 7.70 | 0.025 |
Outer retinal thickness, μm | 183.33 ± 15.94 | 191.33 ± 8.82 | 0.286 | 192.88 ± 13.12 | 189.63 ± 4.34 | 0.555 |